Company Overview and News

8
Citigroup Hires From Rivals for Japan Prime Brokerage Expansion - Bloomberg

2018-07-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JPXGY MZHOF C.WSA DB OSCUF C C.PRL C.PRJ C.PRK C.PRG C.PRC FIG C.WS.B C.PRPCL CGBBW C.WS.A C.PRP C.PRU 8697 8411 MFG C.PRS

3
Japan’s banks turn to new ATM strategies

2018-07-15 thestar.com.my
A WHITE truck was parked outside a supermarket in Mishima, Shizuoka Prefecture, in late June, with a notable message on its side: "Equipped with a counter and ATM".
MZHOF SKLKY 9020 SMFG SMFNF SEBNF SVNBY KDDIY 8306 4689 9437 8303 YAHOY KDDIF RKUNY MBFJF DCM 8361 JOYOF SZKBF RKUNF SHZUY YAHOF 8316 SKLKF MUFG NTDMF 8411 8355 8410 MTU MFG LN

0
Mizuho to halt ATM, online banking services over three-day weekend

2018-07-13 japantimes.co.jp
Mizuho Financial Group Inc., the parent of Mizuho Bank, will temporarily suspend ATM and online banking operations over the three-day weekend starting Saturday to conduct data transfers.
MZHOF 8411 MFG

2
Japanese banks MUFG, Mizuho to stop Iranian transactions

2018-07-12 theedgemarkets
TOKYO (July 12): Japanese banks are moving to stop handling all Iran-related transactions to meet a November deadline set by the United States, after President Donald Trump in May pulled out of a nuclear programme agreement with Tehran.
MZHOF 8306 MUFG 8411 MBFJF MTU MFG

2
Nikkei rises to 1-1/2-week high on Wall Street rally

2018-07-10 thehindubusinessline
Yahoo Japan Corp was up 10 per cent after rising as much as 11.66 per cent.
7261 MZHOF SMFG HCTHY ICLQY SFTBF SMFNF TOELY 8306 4689 532281 YAHOY TOELF MBFJF SFTBY ADTTF MZDAY 532822 YAHOF 8316 MZDAF HCLTECH IDEA MUFG 8411 9984 8035 ATEYY MTU MFG

4
Nikkei rebounds to 1-week high on US jobs data

2018-07-09 thehindubusinessline
Japan's Nikkei share average rebounded to a one-week high on Monday morning as investors took heart from US jobs growth, while Eisai extended its gains to its daily-limit high on optimism for its Alzheimer's drug.
7261 MZHOF PCRFY MZDAY TTDKF BIIB 8306 MZDAF MUFG 8411 MBFJF MTU MFG

4
Nikkei rebounds to 1-week high after U.S. jobs data; Eisai jumps

2018-07-09 reuters
TOKYO, July 9 (Reuters) - Japan’s Nikkei share average rebounded to one-week highs on Monday morning as investors took heart from U.S. jobs growth, while Eisai extended its gains to its daily-limit high on optimism for its Alzheimer’s drug.
7261 MZHOF PCRFY MZDAY TTDKF BIIB 8306 MZDAF MUFG 8411 MBFJF MTU MFG

2
Nikkei falls to 3-month low; banks, inbound tourism stocks weaken

2018-07-05 reuters
TOKYO, July 5 (Reuters) - Japan’s Nikkei share average closed at a three-month low on Thursday as trade tensions spooked investors while shares of banks and firms that benefit from inbound tourism languished.
MZHOF 8306 SZKBF MUFG 8411 JAIRF MBFJF 8355 MTU MFG SHZUY JTTRY

3
Nikkei falls before US-China tariff deadline; banks weaken

2018-07-05 reuters
TOKYO, July 5 (Reuters) - Japan’s Nikkei share average fell on Thursday morning as trade tensions kept activity in check, while banks and index-heavy stocks such as Fast Retailing dragged on the market.
MZHOF NMR 8604 N33 8306 NRSCF MUFG 8411 MBFJF MTU MFG

0
Operations resume at Mizuho Securities online trading service after 2-day suspension

2018-06-28 japantimes.co.jp
Mizuho Securities Co. resumed operations of its online trading service Thursday after suspending it for two and a half days due to a system failure.
MZHOF 8411 MFG

0
Mizuho's Internet Trading System Failure Enters Third Day - Bloomberg

2018-06-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
MZHOF 8411 MFG

0
Mizuho’s online trading platform remains suspended after crash during IPO stock debut in Tokyo

2018-06-27 japantimes.co.jp
Mizuho Securities Co.’s online stock trading services for retail customers remained suspended as of Wednesday morning due to a system glitch, company officials said.
MZHOF 8411 MFG

0
Mizuho’s online trading platform crashes as IPO stock debuts in Tokyo

2018-06-26 japantimes.co.jp
Mizuho Financial Group Inc.’s online stock platform crashed Tuesday, making it harder for individual investors to trade on a day when a company whose initial public offering it underwrote listed on the Tokyo Stock Exchange.
MZHOF 8411 MFG

2
Nikkei ends up as trade war jitters ease, tech shares rally

2018-06-21 reuters
TOKYO (Reuters) - Japan’s Nikkei share average rose on Thursday as concerns over China-U.S. trade issues that hit markets early this week appeared to recede, while technology stocks rallied on the back of Nasdaq’s strong performance.
MZHOF TTDKF 8316 8306 MUFG SMFG 8411 3772 SMFNF MBFJF MTU MFG

2
Nikkei rises as trade jitters ease; tech stock rally

2018-06-21 thehindubusinessline
Japan's Nikkei share average rose on Thursday morning as investor jitters over trade issues that hit markets early this week appeared to recede, while technology stocks rallied on the Nasdaq strong performance overnight.
MZHOF TTDKF 8316 8306 MUFG SMFG 8411 SMFNF MBFJF MTU MFG

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 006591014